Download FREE Sample
Table of Contents
1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Market Estimation
1.4. Market Forecasting
2. Executive Summary
3. Market Overview
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunities
3.1.4. Market Trend
3.2. Industry Speaks
3.3. Technology Trends
4. COVID-19 Impact on Nerve Repair & Regeneration Market
5. Reimbursement Landscape: Snapshot
6. Global Nerve Repair & Regeneration Market- Size &
Forecast (2026-2031), By Product
6.1. Neurostimulation &
Neuromodulation Devices
6.1.1. Internal Neurostimulator
devices
6.1.2. External Stimulator
devices
6.2. Biomaterials
6.2.1. Nerve Conduits
6.2.2. Nerve Wraps
7. Global Nerve Repair & Regeneration Market- Size &
Forecast (2026-2031), By Application
7.1. Neurostimulation &
Neuromodulation Surgeries
7.2. Direct Nerve
Repair/Neurorrhaphy
7.3. Nerve Grafting
7.4. Stem Cell Therapy
8. Global Nerve Repair & Regeneration Market- Size &
Forecast (2026-2031), By Region
8.1. North America (U.S. &
Canada)
8.2. Europe (UK, Germany, France,
Italy, Spain, Rest of Europe)
8.3. Asia Pacific (China, India,
Japan, Rest of Asia Pacific)
8.4. Rest of the World (Latin
America, Middle East & Africa)
9. Competitive Landscape
9.1. Key Players and their
Competitive Positioning
9.1.1. Market Share Analysis
(2022)
9.1.2. Segment-wise Player
Mapping
9.2. Key Strategies Assessment,
By Player (2020-2022)
9.2.1. New Product & Service
Launches
9.2.2. Partnerships, Agreements,
& Collaborations
9.2.3. Mergers & Acquisitions
9.2.4. Geographic Expansion
10. Key Companies Scanned (Indicative List)
10.1. AxoGen Inc.
10.2. Stryker Corporation
10.3. Baxter International Inc.
10.4. Polyganics B.V.
10.5. Boston Scientific Inc.
10.6. Phageneis
10.7. Integra Lifesciences
Corporation
10.8. Cyberonics Inc.
10.9. Medtronic plc.
10.10. Abbott Laboratories
